The concept of myasthenia gravis as a pure disorder of the neuromuscular transmission has probably been an obstacle to the full delineation of the clinical picture of this disease. Thus, careful clinical examination has revealed a series of signs and symptoms connected with myasthenia gravis which cannot be attributed to the defect of transmission of the neuromuscular junction (Simpson, 1960) . Some The diagnosis of rheumatoid arthritis (RA) and of systemic lupus erythematosus (SLE) followed criteria given by the American Rheumatism Association (1959) . SEROLOGICAL TESTS The antiglobulin consumption test (AGCT) for muscle antibodies was performed as described earlier (Aarli and T0nder, 1970) . When the tissue was treated with normal human serum, a small consumption of antiglobulin serum occurred (normal consumption). A consumption four or more times greater than normal was designated 'pathological consumption' (PC) (Aarli and T0nder, 1970) .
Indirect haemagglutination test (IHA) for muscle antibodies was performed using tannic acid-treated red cells sensitized with citric acid extract (CA antigen) of skeletal muscle (Aarli, 1972b) .
Waaler's test for rheumatoid factor (RF) and absorption of RF were performed as earlier (Aarli, 1971b) .
DIRECT IMMUNOFLUORESCENCE (IF) Quick frozen myocardial tissue was stained as described previously (Thunold et al., 1973) with monospecific FITC labelled rabbit antisera against human albumin, IgA, IgG, IgM, fibrinogen, and /l3c/1A-globulin (C3) obtained from Behringwerke AG, Marburg Lahn, West Germany and against Clq (Thunold et al., 1970 Radiographs showed typical rheumatic destruction of finger joints (Fig. 1) . From (Aarli, 1971b The clinical condition was, however, dominated by the rheumatic disorder. There was swelling and symmetrical deformity of MCP and PIP joints, with typical ulnar deviation of the hands and rheumatoid affections of several other joints. Radiographs of her joints showed rheumatoid destruction.
Subcutaneous injection of neostigmine resulted in full but transitory improvement of muscle strength. She was treated with neostigmine, later pyridostigmine, with a satisfactory control of the myasthenic symptoms. She had intermittent diplopia but no other symptoms of muscular fatigue.
There was no radiological evidence of thymic enlargement in 1953 or at later examinations.
She received gold injections, was treated with chloroquine for six years (after manifestation of MG), but was never treated with ACTH or steroids.
She died from sudden cardiac failure at the age of 52 years. The heart was removed at a partial necropsy. It was enlarged (weight 440 g) but showed no signs of valvular defects or obstructing coronary atheromatosis or thrombosis. There were no signs of old or recent infarcts. However, microscopy revealed hypertrophic muscle fibres and small areas of fibrosis (Fig. 2a) . In addition, multiple focal areas of muscle cell vacuolization and necrosis were seen, often accompanied by a slight infiltration of lymphocytes and histiocytes (Fig. 2b, c) . In the pericardium, small perineural lymphocyte infiltrations were found (Fig. 2d) (Fig. 3) and extensive ligamentous calcification (Fig. 4) There was a total clinical remission during pregnancy but the disease recurred during the puerperium.
From the age of 36 years, she had migrating arthralgia and intermittent swelling of small joints of the hands and feet. Clinical examination, however, has on several occasions revealed no sign of synovitis. Radiographs revealed no signs of thymoma. Renal and thyroid function were normal.
Serologicalfindings Muscle and thyroid antibodies, RF and ANF have not been detected.
DISCUSSION
Seven patients with myasthenia gravis (MG) developed clinical signs of arthropathy. One of these had ankylosing spondylitis and one arthralgia without objective signs of arthritis. The other five patients all showed clinical signs of polyarthritis.
The degree of polyarthritis varied from a slight, non-deforming articular affection to a manifest and deforming rheumatoid arthritis (RA) in two of the patients (case 1 and 2). The course of the rheumatoid disease was, from the start, progressively destructive, advancing to an incapacitating stage with ankylosis and severe deformation of several joints. With both patients, the diagnosis was a definite RA, with the modification that high concentrations of LE cells were demonstrated in the serum of case 2.
In these two patients, the myasthenic symptoms were a transitory clinical phase during the development of rheumatoid disease. As the articular symptoms progressed, the myasthenic weakness became less prominent. Similar amelioration of myasthenic symptoms in connection with the appearance of RA has been reported by Oosterhuis and Haas (1968) . Another case of regression of myasthenic symptoms during the development of RA is reported by Storm-Mathisen (1961) .
Serum from case 1 contained both IgG muscle antibodies and RF. In an earlier study, evidence for autoreactivity between the muscle antibodies and RF was presented. Furthermore, RF was also demonstrated in eluates prepared from muscle tissue sensitized with autologous serum (Aarli, 1971b The muscle antibodies in sera from cases 1 and 2 reacted with skeletal as well as heart muscle. Such cross-reactivity was first described by Beutner et al. (1962) . A recent theory postulates that muscle antibodies may be indicators of autoimmune muscle disease (Dawkins and Zilko, 1975) . Case 2 died from sudden cardiac failure and necropsy revealed an enlargement of the heart. There were no signs of rheumatoid myocarditis. The histological findings were a spotty myocardial necrosis accompanied by a mild inflammatory reaction-a common lesion in myasthenia gravis (Russell, 1953; Genkins et al., 1961) . However, IF did not reveal antibody protein or complement factors within the myocardial lesions.
The relationship between muscle pathology and muscle antibodies is not clarified. Beutner et al. (1965) have described in vivo-binding of gamma-globulin only to the sarcolemmalsubsarcolemmal region of skeletal muscle fibres from patients with MG. The concomitant histological lesion was abnormally large numbers of subsarcolemmal nuclei. But this phenomenon was observed only when the IHA test for muscle antibodies was positive. Antibodies of this type are probably directed towards antigens in the sarcolemmal/subsarcolemmal region (Aarli, 1972a) . Such antibodies were not demonstrated in sera from case 1 and 2.
Several patients with concomitant MG and RA are reported in the literature. Sera from a number of these patients are reported to give negative reactions in IF or IHA tests for muscle antibodies (Downes et al., 1966; Szobor et al., 1969; Durance, 1971) . Recent reports have shown that the AGCT also detects antibodies to other muscle antigens (Aarli and T0nder, 1970; Aarli, 1972b) . Therefore, the specificity of the muscle antibodies in MG patients who develop RA seem to differ from that described in other MG patients.
It has been discussed whether the arthritis occurring in MG represents RA or a different form of polyarthritis (Simpson, 1960 (Simpson, , 1964 . The results of the present study clearly show that both definite RA and juvenile RA (case 3) may develop during myasthenia. There are, however, forms of arthropathy, seen in MG (case 7) which are probably not of rheumatoid nature.
In the two patients with SLE (cases 4 and 5) the articular symptoms were mild. In both patients, MG preceded the SLE by several years. The initial symptoms were from extrinsic ocular muscles, a finding indicating that the muscular symptoms were not due to a polymyositis. It is of interest that one of these patients (case 4) gave birth to a child with neonatal myasthenia. In both patients, the myasthenic symptoms gradually faded as indices of SLE appeared. Both exacerbation and remission of muscular symptoms during development of SLE have been reported by several authors (Harvey et al., 1954; Alarcon-Segovia et al., 1963; Goldin and Robbins, 1963; Piemme, 1964; Oosterhuis and de Haas, 1968) . Thymectomy was performed in case 5 without influencing the course of SLE.
The progression of MG in case 6 resembled that of case 2. The former developed a classical ankylosing spondylitis. During the disease, he had a period with myasthenic, edrophoniumsensitive ocular symptoms followed by spontaneous remission of the muscular symptoms. Coexisting ankylosing spondylitis and MG is also reported by Simpson (1960) . The data are however, insufficient to exclude the possibility of this being a pure coincidence.
To summarize, arthritis may develop during the course of MG. The clinical and serological data demonstrate a close relationship between the two disorders. In some patients, the articular symptoms indicate the development of RA. In other patients, the myasthenia may be a prelude to SLE. In still other patients, unspecified arthralgia occurs, where only the future clinical development may reveal the definite diagnosis.
